|Articles|January 2, 2005
- Pharmaceutical Technology-01-02-2005
- Volume 29
- Issue 1
Drug Safety and Access Top Policy Concerns for 2005
Author(s)Jill Wechsler
Safety issues and shortages may slow down new drug development and FDA reforms
Advertisement
Articles in this issue
about 21 years ago
An Overview of the Effect of Moisture on Compaction and Compressionabout 21 years ago
The Pipeline Crisisabout 21 years ago
The Outsourcing Advantages in Formulation Developmentabout 21 years ago
Comparison of EP "Heavy Metals" Test with USP "Conductivity" Testabout 21 years ago
Patheon Places Big Bet with Mova Acquisitionabout 21 years ago
January 2005about 21 years ago
In the Spotlight-January 2005Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Navigating AI, Sustainability, and Operational Resilience
2
Integrating AI and Machine Learning in Drug Discovery and Development
3
Pharmaceutical Supply Chain Resilience in a Shifting Market
4
SÜDPACK Medica to Unveil Next-Generation Sustainable Packaging and Streamlined Services at Pharmapack Europe 2026
5